A citation-based method for searching scientific literature

Ele Ferrannini, Simona Baldi, Silvia Frascerra, Brenno Astiarraga, Tim Heise, Roberto Bizzotto, Andrea Mari, Thomas R Pieber, Elza Muscelli. Diabetes 2016
Times Cited: 259



Ben A Kappel, Michael Lehrke, Katharina Schütt, Anna Artati, Jerzy Adamski, Corinna Lebherz, Nikolaus Marx. Circulation 2017
Times Cited: 58




List of shared articles



Times cited

Organ protection by SGLT2 inhibitors: role of metabolic energy and water conservation.
Adriana Marton, Tatsuroh Kaneko, Jean-Paul Kovalik, Atsutaka Yasui, Akira Nishiyama, Kento Kitada, Jens Titze. Nat Rev Nephrol 2021
13

Effect of Dapagliflozin on Urine Metabolome in Patients with Type 2 Diabetes.
Evdoxia Bletsa, Sebastien Filippas-Dekouan, Christina Kostara, Panagiotis Dafopoulos, Aikaterini Dimou, Eleni Pappa, Styliani Chasapi, Georgios Spyroulias, Anastasios Koutsovasilis, Eleni Bairaktari,[...]. J Clin Endocrinol Metab 2021
1

SGLT2 inhibitors break the vicious circle between heart failure and insulin resistance: targeting energy metabolism.
Xiaodan Wang, Jingyu Ni, Rui Guo, Lan Li, Jing Su, Feng He, Guanwei Fan. Heart Fail Rev 2021
0

Systemic Actions of SGLT2 Inhibition on Chronic mTOR Activation as a Shared Pathogenic Mechanism between Alzheimer's Disease and Diabetes.
Gabriela Dumitrita Stanciu, Razvan Nicolae Rusu, Veronica Bild, Leontina Elena Filipiuc, Bogdan-Ionel Tamba, Daniela Carmen Ababei. Biomedicines 2021
0

Could Sodium/Glucose Co-Transporter-2 Inhibitors Have Antiarrhythmic Potential in Atrial Fibrillation? Literature Review and Future Considerations.
Dimitrios A Vrachatis, Konstantinos A Papathanasiou, Konstantinos E Iliodromitis, Sotiria G Giotaki, Charalampos Kossyvakis, Konstantinos Raisakis, Andreas Kaoukis, Vaia Lambadiari, Dimitrios Avramides, Bernhard Reimers,[...]. Drugs 2021
0

SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: A systematic review and meta-analysis.
Rhanderson Cardoso, Fabrissio P Graffunder, Caique M P Ternes, Amanda Fernandes, Ana V Rocha, Gilson Fernandes, Deepak L Bhatt. EClinicalMedicine 2021
0

Ketone body metabolism in diabetic and non-diabetic heart failure.
Ningjing Qian, Yaping Wang. Heart Fail Rev 2020
3

CaMKII and GLUT1 in heart failure and the role of gliflozins.
M Trum, S Wagner, L S Maier, J Mustroph. Biochim Biophys Acta Mol Basis Dis 2020
6

Empagliflozin improves left ventricular diastolic function of db/db mice.
Julia Moellmann, Barbara M Klinkhammer, Patrick Droste, Ben Kappel, Elias Haj-Yehia, Sebastian Maxeiner, Anna Artati, Jerzy Adamski, Peter Boor, Katharina Schütt,[...]. Biochim Biophys Acta Mol Basis Dis 2020
11

Comparison of mechanisms and transferability of outcomes of SGLT2 inhibition between type 1 and type 2 diabetes.
Oliver Schnell, Paul Valensi, Eberhard Standl, Antonio Ceriello. Endocrinol Diabetes Metab 2020
1